Genomma Lab Internacional Sustainability Profile
Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
DitchCarbon Score
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genomma Lab Internacional's score of 37 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genomma Lab Internacional's reported carbon emissions
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 51,000,000 kg CO2e, comprising 3,100,840 kg CO2e from Scope 1, 4,740,490 kg CO2e from Scope 2, and 44,075,120 kg CO2e from Scope 3 emissions. This data reflects their global operations, with emissions data sourced directly from Genomma Lab Internacional, S.A.B. de C.V. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) nor disclosed any climate pledges. However, they are actively engaged in monitoring and reporting their emissions, which is crucial for transparency and accountability in their climate commitments. In comparison, in 2022, Genomma Lab Internacional's total emissions were approximately 48,000,000 kg CO2e, indicating a slight increase in emissions year-on-year. The breakdown for 2022 shows Scope 1 emissions at 2,737,470 kg CO2e, Scope 2 at 4,041,110 kg CO2e, and Scope 3 at 43,466,980 kg CO2e. Overall, while Genomma Lab Internacional has made strides in emissions reporting, the absence of formal reduction targets highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 134,240 | 000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 109,740 | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Genomma Lab Internacional's Industry?
How Carbon Intensive is Genomma Lab Internacional's Location?
Genomma Lab Internacional's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genomma Lab Internacional has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
